Medical Biochemistry II (MBMB 2200) -2

Medical Biochemistry II (MBMB 2200) -2 - OMPATH

**End of Year Examination for Bachelor of Medicine and Bachelor of Surgery****Date:**.....can't say | **Time:** 2 Hours**Unit Title:** Medical Biochemistry II**Paper A (MBMB ...)****Section B: LAQs & SAQs** - **Understanding Disease Mechanisms:** Integrated metabolism helps a doctor understand how metabolic pathways interact in different tissues, aiding in the recognition of systemic metabolic disorders like diabetes mellitus, obesity, and metabolic syndrome. - **Clinical Decision Making:** Enables better interpretation of laboratory results (e.g., glucose levels, lipid profiles) in the context of the body's overall metabolic state. - **Pharmacological Insights:** Understanding metabolic interrelationships helps doctors predict drug interactions and metabolic side effects, especially in diseases like liver failure or renal impairment. - **Nutritional Management:** Supports dietary planning in patients with chronic illnesses (e.g., advising low-carbohydrate diets in insulin resistance). - **Emergency Care:** Assists in acute cases such as diabetic ketoacidosis or lactic acidosis, where quick understanding of metabolic pathways is crucial. - **Thermogenic Properties:** Brown and beige fat have high mitochondrial density and express uncoupling protein 1 (UCP1), which dissipates energy as heat. This helps in increasing energy expenditure. - **Weight Reduction:** Activation of brown/beige fat promotes lipolysis and fat oxidation, leading to reduction in adipose tissue and body weight. - **Improved Glucose Tolerance:** These tissues increase glucose uptake and insulin sensitivity, thus improving glycemic control in diabetic patients. - **Target for Therapy:** Research is ongoing to identify drugs (like β3-adrenergic agonists or cold exposure mimetics) that stimulate brown/beige fat activity. - **Metabolic Health:** Enhances lipid clearance from blood, reducing risk of atherosclerosis and cardiovascular diseases linked to obesity and diabetes. - Integrated metabolism refers to the **coordination of biochemical pathways** across multiple organs and tissues to meet the energy and biosynthetic demands of the body. - Key metabolic organs include the **liver, muscle, adipose tissue, brain, and kidneys**. - Hormones such as **insulin, glucagon, catecholamines, cortisol**, and **growth hormone** play vital roles in maintaining metabolic balance. - During feeding, **anabolic pathways** are activated (e.g., glycogenesis, lipogenesis), while in fasting, **catabolic pathways** (e.g., glycogenolysis, gluconeogenesis, lipolysis) dominate. - Integration ensures efficient **substrate allocation, energy conservation, and homeostasis**, adapting to physiological states like rest, exercise, stress, or illness. - **Serum enzyme levels** serve as markers of hepatocellular injury or cholestasis. - **Alanine aminotransferase (ALT):** Highly specific to liver; elevation indicates hepatocyte injury. - **Aspartate aminotransferase (AST):** Less specific; also found in muscle and heart; ratio of AST/ALT may help differentiate alcoholic vs non-alcoholic liver disease. - **Alkaline phosphatase (ALP):** Elevated in bile duct obstruction and cholestatic liver diseases. - **Gamma-glutamyl transferase (GGT):** Supports cholestatic diagnosis and alcohol-induced damage. - **Lactate dehydrogenase (LDH):** Less specific but can suggest hepatocellular necrosis. - Monitoring enzyme trends over time helps assess **disease severity, progression, and treatment response**. - **Correct Collection Technique:** Use of sterile containers, avoiding hemolysis and contamination. - **Labeling:** Accurate patient identifiers, date and time of collection are essential. - **Preservation:** Certain tests (e.g., blood gases, hormones) require refrigeration or immediate analysis. - **Transport:** Samples must be sent promptly to the lab to prevent degradation or clotting. - **Pre-analytical Variations:** Diet, timing, and patient posture can affect results; clinicians must understand these. - **Documentation:** Proper record-keeping ensures traceability and supports legal and diagnostic accuracy. - **Blood Glucose:** Evaluates carbohydrate metabolism; used in diagnosis and monitoring of diabetes mellitus. - **Serum Creatinine:** Indicates kidney function; elevated levels suggest impaired glomerular filtration. - **Serum Bilirubin:** Detects liver function or hemolysis; distinguishes between direct and indirect causes of jaundice. - **Serum Electrolytes (Na+, K+):** Monitor hydration status, renal function, and heart rhythm stability. - The Van den Bergh test measures **serum bilirubin** using diazotized sulfanilic acid. - **Direct (Conjugated) bilirubin:** Reacts immediately (within 30 seconds) = direct positive reaction. - **Indirect (Unconjugated) bilirubin:** Requires alcohol as a solubilizer = indirect positive reaction. - **Mixed reaction:** Suggests hepatocellular jaundice. - **Clinical Interpretation:****Direct positive:** Obstructive jaundice (post-hep